ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 914,00
-0,89%
Dow Jones
37 903,29
0,23%
DAX
17 913,58
-0,05%
Brent Oil
84,065
0,63%
Bitcoin
57 665,98
-0,98%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Celcuity Inc (CELC)

  7. Celcuity Inc (CELC) Actualités

CELC Celcuity Inc

16,30
0,00 (0,00%)
Avant marché
Dernière mise à jour : 10:16:42
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Celcuity Inc CELC NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 16,30 10:16:42
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
16,30
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
04/4/202413:05GLOBECelcuity To Present at Upcoming Needham and Stifel Investor..
27/3/202421:01GLOBECelcuity Inc. Reports Fourth Quarter and Full Year 2023..
20/3/202412:05GLOBECelcuity Inc. Schedules Release of Fourth Quarter and Full..
06/3/202413:05GLOBECelcuity to Participate in Leerink Partners Global Biopharma..
28/2/202413:05GLOBECelcuity to Participate in Cowen’s 44th Annual Health Care..
23/2/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202422:05GLOBECelcuity Announces First Patient Dosed in Phase 1b/2..
20/2/202413:05GLOBECelcuity Appoints Eldon Mayer as Chief Commercial Officer
15/2/202423:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202423:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:28EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202422:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202416:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202423:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
22/12/202322:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202316:34EDGAR2Form 144 - Report of proposed sale of securities
06/12/202314:30GLOBECelcuity Presents Preclinical Data on Therapeutic Effects of..
05/12/202323:25EDGAR2Form 8-K - Current report
01/12/202317:02GLOBECelcuity to Present Preclinical Data for Gedatolisib at the..
30/11/202322:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202322:30EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
29/11/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
22/11/202314:15EDGAR2Form S-3/A - Registration statement under Securities Act of..
22/11/202314:05GLOBECelcuity to Participate in the 6th Annual Evercore ISI..
13/11/202320:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202313:35EDGAR2Form 8-K - Current report
13/11/202313:05GLOBECelcuity Inc. Reports Third Quarter 2023 Financial Results..
06/11/202313:30GLOBECelcuity Inc. Schedules Release of Third Quarter 2023..
01/11/202312:05GLOBECelcuity To Present at Upcoming Stifel and Jefferies..
27/10/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/10/202323:15EDGAR2Form 8-K - Current report
07/9/202322:05GLOBECelcuity to Host Virtual Science Day for Investors
01/9/202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202316:58EDGAR2Form 144 - Report of proposed sale of securities
29/8/202322:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202322:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202323:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/8/202323:15EDGAR2Form 8-K - Current report
22/8/202322:05GLOBECelcuity Enters into a Clinical Trial Collaboration and..
22/8/202322:01GLOBECelcuity Announces Plan to Conduct Phase 1b/2 Clinical Trial..
11/8/202323:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:10EDGAR2Form 8-K - Current report
10/8/202322:04GLOBECelcuity Inc. Reports Second Quarter 2023 Financial Results..
03/8/202313:30GLOBECelcuity Inc. Schedules Release of Second Quarter 2023..
31/7/202314:00GLOBECelcuity to Participate in the BTIG Virtual Biotechnology..

Dernières Valeurs Consultées

NASDAQ
CELC
Celcuity
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés